FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use
| Type | Bill |
|---|---|
| Session | 2022 Regular Session |
| Subjects |
Concerning the lawful use of a prescription drug that contains 3,4-methylenedioxymethamphetamine (MDMA) that is approved by the United States food and drug administration.
Bill Summary:
The act states that if the United States food and drug administration approves a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA), and if that medicine has been placed on a schedule of the federal "Controlled Substances Act", other than schedule I, or has been exempted from one or more provisions of such act, then thereafter prescribing, dispensing, transporting, possessing, and using that prescription drug is legal in Colorado only if the medicine is possessed by a person authorized to legally possess such a controlled substance in Colorado.
(Note: This summary applies to this bill as enacted.)
Related Documents & Information
| Date | Version | Documents |
|---|---|---|
| 04/06/2022 | PA1 |
| Activity | Vote | Documents |
|---|---|---|
| Refer House Bill 22-1344 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar. | The motion passed on a vote of 5-0. | Vote summary |
| Activity | Vote | Documents |
|---|---|---|
| Adopt amendment L.001 (Attachment L). | The motion passed without objection. | Vote summary |
| Adopt amendment L.002 (Attachment M). | The motion passed without objection. | Vote summary |
| Refer House Bill 22-1344, as amended, to the Committee of the Whole. | The motion passed on a vote of 11-0. | Vote summary |
| Date | Calendar | Motion | Vote | Vote Document |
|---|---|---|---|---|
| 04/29/2022 | Third Reading | BILL |
34
AYE
0
NO
1
OTHER
|
Vote record |
| Date | Calendar | Motion | Vote | Vote Document |
|---|---|---|---|---|
| 04/08/2022 | Third Reading | BILL |
53
AYE
2
NO
10
OTHER
|
Vote record |
| Date | Location | Action |
|---|---|---|
| 06/08/2022 | Governor | Governor Signed |
| 05/31/2022 | Governor | Sent to the Governor |
| 05/31/2022 | Senate | Signed by the President of the Senate |
| 05/27/2022 | House | Signed by the Speaker of the House |
| 04/29/2022 | Senate | Senate Third Reading Passed - No Amendments |
| 04/28/2022 | Senate | Senate Second Reading Special Order - Passed - No Amendments |
| 04/27/2022 | Senate | Senate Committee on Health & Human Services Refer Unamended - Consent Calendar to Senate Committee of the Whole |
| 04/13/2022 | Senate | Introduced In Senate - Assigned to Health & Human Services |
| 04/08/2022 | House | House Third Reading Passed - No Amendments |
| 04/07/2022 | House | House Second Reading Special Order - Passed with Amendments - Committee |
| 04/05/2022 | House | House Committee on Public & Behavioral Health & Human Services Refer Amended to House Committee of the Whole |
| 03/28/2022 | House | Introduced In House - Assigned to Public & Behavioral Health & Human Services |
Prime Sponsor
Sponsor
Co-Sponsor
| Effective Date | Chapter # | Title | Documents |
|---|---|---|---|
| 08/10/2022 | 461 | FDA-approved Prescription MDMA Drug Use |